A Study for the Assessment of the Words Used by Patients and Physicians to Express Asthma Symptoms
This study has been completed.
Sponsor:
AstraZeneca
Information provided by:
AstraZeneca
ClinicalTrials.gov Identifier:
NCT00986219
First received: September 22, 2009
Last updated: December 16, 2009
Last verified: December 2009
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The purpose of the study is to evaluate the concordance of the most frequently used words by the patients and the physicians to express asthma symptoms and the limitations of daily activities caused by asthma.
| Condition |
|---|
|
Asthma |
| Study Type: | Observational |
| Study Design: | Observational Model: Case-Only Time Perspective: Cross-Sectional |
| Official Title: | A Cross Sectional Study for the Assessment of the Words Used by Patients and Physicians to Express Asthma Symptoms and the Limitations of Daily Activities in Primary Care. The " Asthma Language " Survey |
Resource links provided by NLM:
Further study details as provided by AstraZeneca:
Primary Outcome Measures:
- The concordance of the most frequently used words by the patients and the physicians to express asthma symptoms and the limitations of daily activities caused by asthma [ Time Frame: Day 1 ] [ Designated as safety issue: No ]
Secondary Outcome Measures:
- The most frequently used words (lexical intensity) by the patient and the physician to express asthma symptoms and the limitations of daily activities. [ Time Frame: Day 1 ] [ Designated as safety issue: No ]
- The concordance of words used by physicians and patients according to the level of asthma control (as assessed by ACQ). [ Time Frame: Day 1 ] [ Designated as safety issue: No ]
- The actions recommended by the physician or those initiated by the patient and are associated with words that express symptoms. [ Time Frame: Day 1 ] [ Designated as safety issue: No ]
| Enrollment: | 696 |
| Study Start Date: | September 2009 |
| Study Completion Date: | December 2009 |
| Groups/Cohorts |
|---|
| Asthma Language between patients and physicians |
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Probability Sample |
Study Population
Primary care patients with persistent asthma treated with inhaled corticosteroid-based maintenance treatment for at least 6 months and followed up by thep hysician for at least the same period of time.
Criteria
Inclusion Criteria:
- Diagnosis of persistent asthma treated with inhaled corticosteroid-based maintenance treatment for at least 6 months and followed up by the investigator for at least the same period of time
Exclusion Criteria:
- Patient with a cardiac disease (congestive heart failure, coronary heart disease)
- Patient with a respiratory disease other than asthma (COPD, sleep apnoea syndrome)
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00986219
Locations
| Greece | |
| Research Site | |
| Patras, Achaia, Greece | |
| Research Site | |
| Agrinio, Aitoloakarnanias, Greece | |
| Research Site | |
| Thermo, Aitoloakarnanias, Greece | |
| Research Site | |
| Naupaktos, Aitoloakarnania, Greece | |
| Research Site | |
| Argos, Argolida, Greece | |
| Research Site | |
| Arta, Artas, Greece | |
| Research Site | |
| Athens, Attiki, Greece | |
| Research Site | |
| Peraious, Attiki, Greece | |
| Research Site | |
| Livadia, Biotias, Greece | |
| Research Site | |
| Chania, Crete, Greece | |
| Research Site | |
| Herakleion, Crete, Greece | |
| Research Site | |
| Rethimno, Crete, Greece | |
| Research Site | |
| Siros, Cyclades, Greece | |
| Research Site | |
| Rodos, Dodekanisou, Greece | |
| Research Site | |
| Drama, Drammas, Greece | |
| Research Site | |
| Kastoria, Florinas, Greece | |
| Research Site | |
| Amfisa, Fokidos, Greece | |
| Research Site | |
| Pirgos, Ilia, Greece | |
| Research Site | |
| Veroia, Imathia, Greece | |
| Research Site | |
| Ioannina, Ioanninon, Greece | |
| Research Site | |
| Karditsa, Karditsis, Greece | |
| Research Site | |
| Chrisoupoli, Kavalas, Greece | |
| Research Site | |
| Kavala, Kavalas, Greece | |
| Research Site | |
| Loutraki, Korinthia, Greece | |
| Research Site | |
| Ptolemaida, Kozani, Greece | |
| Research Site | |
| Ksanthi, Ksanthis, Greece | |
| Research Site | |
| Larisa, Larisas, Greece | |
| Research Site | |
| Farsala, Larrisa, Greece | |
| Research Site | |
| Volos, Magnisia, Greece | |
| Research Site | |
| Kalamata, Messinia, Greece | |
| Research Site | |
| Aikaterini, Peierias, Greece | |
| Research Site | |
| Edessa, Pella, Greece | |
| Research Site | |
| Komotini, Rodopi, Greece | |
| Research Site | |
| Serres, Serron, Greece | |
| Research Site | |
| Igoumenitsa, Thesprotia, Greece | |
| Research Site | |
| Salonika, Thessalonikis, Greece | |
| Research Site | |
| Trikala, Trikalon, Greece | |
| Research Site | |
| Chalkida, Greece | |
| Research Site | |
| Chalkidiki, Greece | |
| Research Site | |
| Lakonia, Greece | |
Sponsors and Collaborators
AstraZeneca
Investigators
| Principal Investigator: | Mina Gaga, MD | Director of the 7th Respiratory Clinic, Sotiria Hospital, Athens, Greece |
| Study Director: | Panagiotis Pontikis, Dr. | Marketing Company Medical Director, AstraZeneca Greece |
More Information
No publications provided
| Responsible Party: | MC MD, AstraZeneca |
| ClinicalTrials.gov Identifier: | NCT00986219 History of Changes |
| Other Study ID Numbers: | NIS-RGR-DUM-2009/1 |
| Study First Received: | September 22, 2009 |
| Last Updated: | December 16, 2009 |
| Health Authority: | Greece: National Organization of Medicines |
Keywords provided by AstraZeneca:
|
Asthma Language Symptoms, Limitation of Daily activities |
Patients Physicians Greece |
Additional relevant MeSH terms:
|
Asthma Bronchial Diseases Respiratory Tract Diseases Lung Diseases, Obstructive Lung Diseases |
Respiratory Hypersensitivity Hypersensitivity, Immediate Hypersensitivity Immune System Diseases |
ClinicalTrials.gov processed this record on May 19, 2013